NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE94275 Query DataSets for GSE94275
Status Public on Aug 24, 2017
Title Cancer-specific retargeting of BAF complexes by a prion-like domain [ChIP-Seq]
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Alterations in the function of transcriptional regulators can orchestrate oncogenic programs that are critical for the transformation and survival of cancer cells. Here we show that the BAF chromatin remodeling complex, which is mutated in over 20% of human tumors, interacts with EWSR1, a member of the FET family of proteins containing prion-like domains that are frequent partners in oncogenic fusions with transcription factors. In Ewing sarcoma, characterized by the EWS-FLI1 fusion, we find that the BAF complex is recruited by EWS-FLI1 to tumor specific enhancers at GGAA microsatellite repeats and contributes to the activation of target genes. This process depends on tyrosine residues that are necessary for the aggregation properties of the EWSR1 prion-like domain and is a neomorphic feature of EWS-FLI1 compared to the wild type ETS transcription factor FLI1. Furthermore, fusion of short fragments of the EWSR1 prion-like domain to FLI1 is sufficient to recapitulate EWS-FLI1-mediated gene expression. Our studies demonstrate that the aggregation properties of prion-like domains can retarget chromatin regulatory complexes to establish and maintain oncogenic gene expression and proliferation.
 
Overall design ChIP-seq for the BAF complex subunits BAF155 and SMARCA2 in Ewing sarcoma cells (SK-N-MC). EWS-FLI1 was knocked-down with lentiviral shRNA. HA-tagged EWSR1 was expressed in Ewing sarcoma cells (A673) using a lentiviral expression vector and ChIP-seq was performed using an anti-HA antibody.
ChIP-seq for the histone modification H3K27ac, the transcription factor FLI1 and the BAF subunit BAF155 in mesenchymal stem cells (MSC). EWS-FLI1, wild-type FLI1 and the mutant proteins EWS(YS37)-FLI1, SYGQ2-FLI1 and BAF47-FLI1 were expressed in MSCs with lentiviral expression vectors. The FLI1 antibody used recognizes FLI1, EWS-FLI1 and the mutant proteins.

Raw data not provided for primary cells due to patient privacy concerns. Submitter states that the raw data for these samples will be submitted to dbGaP.
 
Contributor(s) Boulay G, Rivera M
Citation(s) 28844694
Submission date Jan 30, 2017
Last update date May 15, 2019
Contact name Sowmya Iyer
E-mail(s) sowmya.iyer@mgh.harvard.edu
Organization name Massachusetts General Hospital
Department Pathology
Street address 149 13th St
City Boston
State/province MA
ZIP/Postal code 02129
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (43)
GSM2472081 HA ChIP-seq in A673 cell line infected with GFP
GSM2472082 HA ChIP-seq in A673 cell line infected with HA-EWSR1
GSM2472083 BAF155 ChIP-seq in MSC1 infected with control
This SubSeries is part of SuperSeries:
GSE94278 Cancer-specific retargeting of BAF complexes by a prion-like domain
Relations
BioProject PRJNA369229
SRA SRP098569

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE94275_RAW.tar 10.2 Gb (http)(custom) TAR (of BW)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap